Daault Adds Scientific and Lab Informatics Power Via Accelrys

V LIZY, FRANCE and WASHINGTON - Dassault Syst mes has introduced its newest brand, BIOVIA.

The new brand is a combination of Dassault Syst mes' own activities in bioIntelligence, its collaborative 3DEXPERIENCE technologies, and the leading life sciences and material sciences applications from the recent acquisition of Accelrys. The newly acquired company's solutions focus on biological, chemical and materials modeling and simulation, research and open collaborative discovery, enterprise laboratory and quality management, and process manufacturing intelligence.

Dassault Syst mes' BIOVIA is now the largest and deepest portfolio for the biological, chemical and material modeling, simulation and production domains. BIOVIA's list of 2,000+ customers includes numerous Fortune 500 companies, such as Sanofi, Pfizer, GSK, AstraZeneca, Du Pont, Shell, BASF, P&G, Unilever and L'Or al.

BIOVIA will provide enterprise-wide scientific, biological, chemical and material experiences, with next-generation applications, services, and content access and delivery leveraging Dassault Syst mes' 3DEXPERIENCE business platform. From material design to molecular simulation to chemical manufacturing, it is Dassault Syst mes' vision that BIOVIA will act as a disruptive catalyst to deliver virtual scientific universes capable of harmonizing products, nature and life.

Said Bernard Charl s, President & CEO, Dassault Syst mes, The integration of Accelrys' powerful applications with our 3DEXPERIENCE platform will create a new collaborative environment for advanced biological, chemical and materials experience development. With the power of BIOVIA, we will model the entire biosphere.

The integration of the company's 3DEXPERIENCE platform with Accelrys' strong suite of applications opens up a wide opportunity to support and develop systemic collaboration, project management, data and content reuse, traceability, and other processes, applications and integrations that are absolutely critical to scientific industries, including pharmaceutical companies that are facing significant innovation and drug discovery challenges.

Key innovators are using BIOVIA solutions to explore and bring to market new materials, such as smart coatings, lighter, stronger composites, and ecosustainable material innovations.

Such companies are fast approaching the point of using material as a variable, not a constraint. To do so, the ability to manage product information at the molecular level in a scalable manner is essential throughout the value chain. In addition, today's aggressive industrialization of research, development and manufacturing processes is driving the adoption of an integrated business platform capable of handling diverse information types in collaborative and compliant environments.

LINK:	http://www.cgw.com/Press-Center/News/2014/Dassault-Adds-Scientific-and...
	See more stories from cwg

Most recent headlines